MedTrace Logo

Evaluation of a Teaching Curriculum on Disruptive Behaviour Disorders

NCT03151187 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 278

Last updated 2018-01-31

No results posted yet for this study

Summary

The investigators have initiated an education program for residents on the diagnosis and management of disruptive behavior disorders in children. These will be presented as two 2-hour modules to be delivered at an academic half-day for pediatric trainees across Canada. We plan to evaluate the effectiveness of the curriculum by administering a pre and post test. Pediatric residents in Canada all participate in a practical assessment of their skills (an Observed Structured Clinical Examination or OSCE). The investigators plan to develop on OSCE station which assesses the curriculum and randomize programs to do the curriculum either before or after the OSCE. This will help us determine how effective the curriculum is at teaching about disruptive behaviours.

Conditions

  • Disruptive Behavior

Interventions

OTHER

Teaching intervention

Two two hour teaching modules on the diagnosis and treatment of disruptive behaviour disorders in children and youth

Sponsors & Collaborators

  • University of Manitoba

    collaborator OTHER

  • University of Calgary

    collaborator OTHER

  • Dalhousie University

    collaborator OTHER

  • Children's Hospital of Western Ontario

    collaborator OTHER

  • Northern Ontario School of Medicine

    collaborator OTHER

  • McMaster University

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • Children's Hospital of Eastern Ontario

    lead OTHER

Principal Investigators

  • Asif Doja, MD · Children's Hospital of Eastern Ontario

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-05-31
Completion
2018-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03151187 on ClinicalTrials.gov